Screening for HIV: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.

@article{Chou2012ScreeningFH,
  title={Screening for HIV: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.},
  author={Roger Chou and Shelley S. Selph and Tracy L Dana and Christina Bougatsos and Bernadette Zakher and Ian Blazina and Philip Todd Korthuis},
  journal={Annals of internal medicine},
  year={2012},
  volume={157 10},
  pages={
          706-18
        }
}
  • Roger Chou, Shelley S. Selph, +4 authors Philip Todd Korthuis
  • Published in Annals of internal medicine 2012
  • Medicine
  • BACKGROUND A 2005 U.S. Preventive Services Task Force (USPSTF) review found good evidence that HIV screening is accurate and that antiretroviral therapy (ART) for immunologically advanced disease is associated with substantial clinical benefits, but insufficient evidence to determine the effects on transmission or in less immunologically advanced disease. PURPOSE To update the 2005 USPSTF review on benefits and harms of HIV screening in adolescents and adults, focusing on research gaps… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 26 CITATIONS

    The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review

    VIEW 7 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 60 REFERENCES

    Effect of early versus deferred antiretroviral therapy for HIV on survival.

    VIEW 5 EXCERPTS
    HIGHLY INFLUENTIAL

    Current methods of the US Preventive Services Task Force: a review of the process.

    VIEW 20 EXCERPTS
    HIGHLY INFLUENTIAL

    Prevention of HIV-1 infection with early antiretroviral therapy.

    VIEW 6 EXCERPTS
    HIGHLY INFLUENTIAL

    Antiretroviral Therapy Cohort Collaboration (ART-CC). Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1

    • E Lanoy, M May, +3 authors G Chêne
    • RNA measurements. AIDS
    • 2009
    VIEW 2 EXCERPTS
    HIGHLY INFLUENTIAL

    Screening for HIV: Systematic Review to Update the 2005 U.S. Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality. [Forthcoming

    • R Chou, S Selph, +3 authors I Blazina
    • 2005
    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL